Extraventricular neurocytoma with atypical features and ganglionic differentiation

[1]  R. Tuncer,et al.  A case of extraventricular neurocytoma of the spinal cord , 2008, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  J. Roh,et al.  Changing ischaemic lesion patterns in adult moyamoya disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  J. Emery,et al.  Genetics and blood--haemoglobinopathies and clotting disorders. , 2007, Australian family physician.

[4]  R. Saxena,et al.  Hypercoagulable State in Five Thalassemia Intermedia Patients , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[5]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[6]  K. Jellinger.  Russell & Rubinstein's Pathology of Tumors of the Nervous System , 2007 .

[7]  H. Budka,et al.  OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms , 2007, Histopathology.

[8]  W. Friedman,et al.  Pontine Atypical Neurocytoma: Case Report , 2006, Neurosurgery.

[9]  R. Delfini,et al.  Central neurocytoma: a novel appraisal of a polymorphic pathology Our experience and a review of the literature , 2006, Neurosurgical Review.

[10]  D. Rades,et al.  Treatment recommendations for the various subgroups of neurocytomas , 2006, Journal of Neuro-Oncology.

[11]  L. Thompson.  World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours , 2006, Ear, nose, & throat journal.

[12]  Takashi Yoshiura,et al.  Moyamoya Syndrome in a Splenectomized Patient With β-Thalassemia Intermedia , 2006 .

[13]  D. Loussouarn,et al.  Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients , 2005, Histopathology.

[14]  N. Venketasubramanian,et al.  Recurrent Cerebral Infarction in Beta Thalassaemia major , 2004, Cerebrovascular Diseases.

[15]  D. Rades,et al.  Prognostic value of the MIB-1 labeling index for central neurocytomas , 2004, Neurology.

[16]  J. Curé,et al.  Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. , 2002, Blood.

[17]  D. Brat,et al.  Extraventricular Neurocytomas: Pathologic Features and Clinical Outcome , 2001, The American journal of surgical pathology.

[18]  M. Kornfeld.  Russell and Rubinstein's pathology of tumors of the nervous system, sixth edition , 1999 .

[19]  I. Mackenzie.  Central neurocytoma , 1999, Cancer.

[20]  M. Avril,et al.  Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study. , 1999, Cancer.

[21]  A. Mukherjee.  Moyamoya disease and beta-thalassemia. , 1995, The Journal of the Association of Physicians of India.

[22]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[23]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[24]  Lucien J. Rubinstein,et al.  Pathology of Tumours of The Nervous System , 1971 .